Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease

Clinical trial NCT00319046 · COMPLETED

Trial details

NCT number: NCT00319046
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease Type 1

Start date: 2006-02-01
Primary completion: 2010-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.